Research Paper Volume 15, Issue 5 pp 1445—1474

Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments

class="figure-viewer-img"

Figure 8. Relationships between GNG7 expression and clinicopathological parameters. Associations between the expression of GNG7 and sex (A), age (B), race (C), tumor grade (D), histological subtypes (E), nodal metastasis status (F), cancer stage (G), Helicobacter pylori infection status (H), and TP53 mutation status (I) of patients with STAD (UALCAN). STAD, stomach adenocarcinoma. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control. (The asterisks above the error bar represent the comparison to the normal sample group, whereas the asterisks above the secondary line represent the comparison between groups indicated by the line).